Prophylaxis of heterotopic ossification-an updated review

被引：121
作者：
Baird E.O. [2 ]
Kang Q.K. [1 ,2 ]
机构：
[1] Clemson University, Department of Bioengineering, Clemson, SC
[2] Medical University of South Carolina, Department of Orthopaedic Surgery, Charleston, SC
来源：
Journal of Orthopaedic Surgery and Research | / 4卷 / 1期
关键词：
Indomethacin; Bone Morphogenetic Protein; Heterotopic Ossification; Acetabular Fracture; Diffuse Idiopathic Skeletal Hyperostosis;
D O I：
10.1186/1749-799X-4-12
中图分类号：
学科分类号：
摘要：
Heterotopic ossification (HO) is defined as the process by which trabecular bone forms outside of the skeletal structure, occupying space in soft tissue where it does not normally exist. The current popular prophylactic treatment modalities include non-steroidal anti-inflammatory drugs (NSAIDs) and radiation therapy, although the literature remains inconclusive as to which is superior. Additionally, both treatments can lead to adverse effects to the patient. Recently there have been several studies attempting to identify new aspects of the etiology of heterotopic bone formation and introduce new prophylactic modalities with increased efficacy and fewer side effects. For this review, we selectively retrieved articles from Medline published from 1958-2008 on the prophylaxis of HO with the aim of assisting readers in quickly grasping the current status of research and clinical aspects of HO prophylaxis.
引用
收藏
相关论文
共 72 条
  • [1] Bossche L.V., Vanderstraeten G., Heterotopic ossification: A review, Journal of Rehabilitation Medicine, 37, 3, pp. 129-136, (2005)
  • [2] Hannallah D., Peng H., Young B., Usas A., Gearhart B., Huard J., Retroviral Delivery of Noggin Inhibits the Formation of Heterotopic Ossification Induced by BMP-4, Demineralized Bone Matrix, and Trauma in an Animal Model, Journal of Bone and Joint Surgery - Series A, 86, 1, pp. 80-91, (2004)
  • [3] Andreu Martinez F.J., Martinez Mateu J.M., Tormo Ferrero V., The role of radiotherapy for prevention of heterotopic ossification after major hip surgery, Clin Transl Oncol, 9, pp. 28-31, (2007)
  • [4] Balboni T.A., Gobezie R., Mamon H.J., Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis, International Journal of Radiation Oncology Biology Physics, 65, 5, pp. 1289-1299, (2006)
  • [5] Board T.N., Karva A., Board R.E., Gambhir A.K., Porter M.L., The prophylaxis and treatment of heterotopic ossification following lower limb arthroplasty, Journal of Bone and Joint Surgery - Series B, 89, 4, pp. 434-440, (2007)
  • [6] Warren S.B., Jr F. B.A., Intramedullary nailing of tibial nonunions, Clin Orthop, pp. 236-243, (1992)
  • [7] Shehab D., Elgazzar A.H., Collier B.D., Heterotopic ossification, Journal of Nuclear Medicine, 43, 3, pp. 346-353, (2002)
  • [8] Lo T.C.M., Radiation therapy for heterotopic ossification, Seminars in Radiation Oncology, 9, 2, pp. 163-170, (1999)
  • [9] Pakos E.E., Pitouli E.J., Tsekeris P.G., Papathanasopoulou V., Stafilas K., Xenakis T.H., Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: The experience of a combined therapeutic protocol, Int Orthop, 30, pp. 79-83, (2006)
  • [10] Harder A.T., An Y.H., The mechanisms of the inhibitory effects of nonsteroidal anti-inflammatory drugs on bone healing: A concise review, Journal of Clinical Pharmacology, 43, 8, pp. 807-815, (2003)
12345678